Analyst Ratings For NASDAQ:APVO – Aptevo Therapeutics (NASDAQ:APVO)
Today, Roth Capital initiated coverage on NASDAQ:APVO – Aptevo Therapeutics (NASDAQ:APVO) with a Buy with a price target of $12.00.
Some recent analyst ratings include
- 4/11/2018-Roth Capital initiated coverage with a Buy rating.
- 10/5/2017-Piper Jaffray Reiterated Rating of Overweight .
Recent Insider Trading Activity For NASDAQ:APVO – Aptevo Therapeutics (NASDAQ:APVO)
NASDAQ:APVO – Aptevo Therapeutics (NASDAQ:APVO) has insider ownership of 15.60% and institutional ownership of 33.04%.
- On 3/19/2018 Marvin L White, Insider, sold 100,000 with an average share price of $2.93 per share and the total transaction amounting to $293,000.00.
- On 11/15/2017 Randy Joe Maddux, VP, bought 25,000 with an average share price of $2.76 per share and the total transaction amounting to $69,000.00.
Recent Trading Activity for NASDAQ:APVO – Aptevo Therapeutics (NASDAQ:APVO)
Shares of NASDAQ:APVO – Aptevo Therapeutics closed the previous trading session at 3.59 up +0.31 9.47% with 3.4600000381469727 shares trading hands.